Loading Events

« All Events

AD/PD 2023

March 28 - April 1

AD/PD 2023

International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders

March 28 – April 1, 2023 | Gothenburg, Sweden, and online

The organisers invite you to join them at the upcoming AD/PD™ 2023 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders. The ground-breaking series of Alzheimer’s and Parkinson’s Diseases Conferences attract international medical and scientific professionals worldwide. The Conference remains at the forefront of unravelling the mechanisms and improving the treatment of Alzheimer’s, Parkinson’s, and other related neurodegenerative diseases. AD/PD™ Conferences uniquely combine distinct neurodegenerative diseases in one setting and examine their similarities and differences; a strong focus is mechanisms of disease, prevention, and therapy.

The AD/PD™ Conference has become the main event of the year in the field of neurodegenerative diseases, attracting leading medical and scientific professionals from around the world. AD/PD™ is now an annual meeting, with a continuing focus on the ADVANCES IN SCIENCE & THERAPY of Alzheimer’s and Parkinson’s Diseases and related neurological disorders.

The forthcoming AD/PD™ meeting, in 2023 will take place as a Hybrid Conference in the vibrant city of Gothenburg, Sweden, and online.

Programme

The AD/PD™ series of conferences have always been notable for an excellent program that balances cutting-edge scientific research and advanced clinical discussions. AD/PD™ 2023 will continue that tradition with sessions of Forum Discussions, Symposia, Oral and Poster Presentations devoted to latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.

Partial list of confirmed speakers:

  • NEXT GENERATION RNA BASED THERAPEUTICS, Ada Yonat (Israel)
  • THE FUTURE OF PD THERAPY; WHY MULTI TARGET DRUGS,  Moussa Youdim (Israel)
  • CSF AND BLOOD BIOMARKERS FOR AD – THEIR ROLE IN SCREENING, DIAGNOSTICS AND THERAPY MONITORING, Kaj Blennow (Sweden)
  • TRANSLATIONAL NEUROPATHOLOGY: BEGINNING AT THE END TO INFORM THE BEGINNING, Melissa Murray (USA)

Abstract Submission

Abstracts must be submitted online. Faxed or emailed abstracts will not be considered.

Abstract Submission Closes Wednesday, September 21, 2022, at Midnight CET.

Note all efforts are made to send notification by the planned date of November 2022. Should there be any delays with the selection process, the revised date will be posted online.

 

Submit an abstract

Listen to our podcast discussing AD/PD 2022

Venue

Gothia Towers
Mässans gata 24
Gothenburg, 412 51 Sweden
+ Google Map
Translate »